Penicillin skin testing is a safe and effective tool for evaluating penicillin allergy in the pediatric population

Stephanie J Fox1, Miguel A Park1

  • 1Division of Allergic Diseases, Mayo Clinic, Rochester, Minn.

Insights

Penicillin skin testing is safe and effective for evaluating penicillin allergy in children. This study found no adverse reactions to the skin test itself, demonstrating its utility in pediatric allergy assessment.

Area of Science:

  • Pediatric Allergy and Immunology
  • Clinical Pharmacology
  • Diagnostic Testing

Background:

  • Penicillin skin testing is validated for adult penicillin allergy assessment.
  • Commercial penicillin skin test reagents (e.g., Pre-Pen) are not FDA-approved for pediatric use.
  • Limited data exists on the safety and validity of penicillin skin testing in children.

Purpose of the Study:

  • To evaluate the safety and effectiveness of penicillin skin testing in children with a history of penicillin allergy.
  • To compare the rate of positive penicillin skin tests in children versus adults.

Main Methods:

  • Children under 18 with a history of penicillin allergy underwent penicillin skin testing.
  • Demographics, skin test results, and subsequent reactions to penicillin or the skin test were recorded.
  • Chi-squared test was used to compare positive skin test rates between pediatric and adult populations.

Main Results:

  • Of 778 children tested, 8.5% had a positive skin test, and 1.1% had an equivocal result.
  • Children were significantly more likely to have a positive penicillin skin test compared to adults (8.5% vs. 3.6%).
  • No adverse reactions to the penicillin skin testing procedure were observed in any children.

Conclusions:

  • Penicillin skin testing is a safe diagnostic tool for evaluating penicillin allergy in pediatric patients.
  • The testing demonstrated effectiveness in identifying children with penicillin allergy.
  • Findings support the expanded use of penicillin skin testing in the pediatric population.
Abstract

Related Concept Videos

Allergic Reactions: Anaphylaxis01:30

Allergic Reactions: Anaphylaxis

Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin,...
275
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
400
Drug Toxicity: Allergic Reactions01:30

Drug Toxicity: Allergic Reactions

Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial...
206
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
405
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
547
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.3K